Alkermes Shares Drop After Mixed Q2; Guidance Midpoint Misses Street Estimates
Alkermes shares slid in pre-market trading after the company reported Q2 2026 results. While adjusted EPS beat consensus and revenue outpaced estimates, the reaffirmed full-year 2026 revenue guidance midpoint came in below analyst projections, prompting a pullback in a stock that had rallied substantially year-to-date.